The changes in body composition and functions that occur in the ageing population include decreases in skeletal muscle mass, strength, and mobility. These decreases in muscle mass and strength are collectively called sarcopenia, which is associated with frailty and falls
among elderly individuals than among young adults, even without the presence of other overt nutrient deficiencies
5, 6.
Many interventions, including dietary supplementation regimens, such as supplementation with protein and omega-3 fatty acids 3,7 , and exercise interventions 8 or combinations of the two, have been tested
9.
Supplementation with vitamin D is one possible intervention. Vitamin D supplementation has been promoted as having positive effects on older persons, particularly with regard to the risk of falls and fractures 10 . An increased risk of falls is a consequence of low muscle strength and mass 11 , and sarcopenia is a risk factor for fractures in elderly individuals 12 . Although many researchers have tried to test the effects of vitamin D supplementation on muscle function, the results remain controversial, and it is still hard to conclude whether vitamin D supplementation has an effect on muscle strength in elderly individuals 6 . The aim of our meta-analysis was to investigate the effects of vitamin D supplementation (with or without calcium) on muscle function among community-dwelling elderly individuals based on the results from randomized controlled clinical trials (RCTs). Methods
I. Literature Review
Published RCTs on sarcopenia and vitamin D supplementation were identified through a comprehensive PubMed and Medline search (from January 2000 to June 2018) using a variety of keywords and subject headings related to sarcopenia, vitamin D supplementation, muscle strength and elderly individuals. We conducted additional searches of Egyptian Knowledge Bank and the cited references of previously published reviews, and we discussed the topic with several experts in the field. Published descriptive and analytical observational studies dealing with sarcopenia and vitamin D were excluded. We did not attempt to locate any unpublished studies. Only RCTs with elderly community-dwelling individuals >60 years of age were included. We applied no restrictions with regard to the dose, forms and duration of vitamin D supplementation or the duration of follow-up; we included studies regardless of their use of calcium supplements and dietary advice. Measures of muscle function included the determination of muscle strength by the hand grip strength (HGS) test and the measurement of physical performance by the timed up-and-go test (TUG). These measures were compared before and after intervention for both groups (vitamin D supplementation versus placebo).
II. Data Extraction
Only 14 RCTs out of 2408 studies met the inclusion criteria and were included in this meta-analysis. A copy of each RCT was obtained, and relevant data were abstracted by the first author (T.T.A.) for a quantitative overview. In case of discrepancies or when the information presented in a study was unclear, the data was extracted by a second reviewer (M.F.A.) to resolve the discrepancy.
III. Statistical Methods for Meta-Analysis
Mean differences between cases and controls groups were calculated by subtracting the mean of the outcome of each result in each paper at the end of the study from the mean at the baseline or the start of the same study; Microsoft Excel 2010 was used for these calculations. The pooled mean differences were obtained by weighing each study by the inverse variance of the effect measure on a logarithmic scale. This approach to pooling the results assumes that the study populations being compared were similar and hence corresponds to a fixed effect analysis. The validity of pooling the mean differences was tested (test of homogeneity) using the chi-square test. A violation of this test suggests that the studies being pooled differ from one another. In the presence of significant heterogeneity of the effect measure among studies being compared, we performed a random effect analysis that was based on the method described by Der Simonian and Laird. The random effect analysis accounts for inter-study variation. Because the test of homogeneity has low power, we reported the figures of the random effect analysis even in the absence of significant heterogeneity. All statistical analyses pertaining to the 14 pooled RCTs were performed with STATA version 14.0 (Stata Corp. 2015, College Station, Texas, USA).
RESULTS
We included 14 RCTs, with a total of 2127 participants aged 60 years and older. The average age of the included participants was 68.8 years (ranging from 60 to 88 years). The ratio of women to men was approximately 3.25:1 (1627/500). All selected studies reported randomization in their design. The participants were all community-dwelling elderly individuals who were generally in good agerelated health. All studies excluded patients with acute illnesses. Vitamin D was measured as the 25(OH)D concentration in all included RCTs using chromatographic methods, radioimmunoassays (DiaSorin Inc., Stillwater, MN, USA), the IDS gamma-B 25-OH immunoassay (IDS, Tyne & Wear, UK), and the Liaison method (DiaSorin Inc.). One RCT study did not report which method had been used. The mean baseline concentration of vitamin D ranged from 11 to 55 nmol/L. One RCT used different supplementation dosages, and another RCT used different durations of follow-up, and we considered each one as two clinical trials. Vitamin D3 supplementation was administered orally at various doses (ranged from 400 -3333 IU) and for different treatment periods (ranged from 3-24 months)
Season was an important covariate as a result of internal vitamin D production due to exposure to ultraviolet-B radiation. The seasons during which the clinical trials were conducted were not documented in all studies.
Seven of the fourteen included RCTs added calcium supplements to the vitamin D supplements. The dose of calcium supplementation ranged from 500 to 1000 mg. Two studies evaluated the overall nutrient intake in addition to supplementation.
Other variables, such as body mass index, ethnicity and smoking, were usually not considered. The dropout rate was reported in 2 RCTs as 10% and 22%. In one RCT, the authors noted that the dropout rate was low without providing more details; in 11 RCTs, the dropout rate was not reported at all.
Compliance was not reported in 3 of the 14 RCTs. In 8 RCTs, the compliance was reported to be good. In 2 RCTs, the compliance rate was 100% for the participants completing the study. In one RCT, it was stated that a daily compliance calendar had been used but the results were not reported. One RCT did not mention whether it had been blinded. We found an improvement in mobility and muscle function in 10 RCTs.
Study outcomes
The pooled mean difference in HGS was higher in the vitamin D supplementation group than in the control group. The pooled mean difference in the TUG test was slightly lower in the vitamin D supplementation group than in the control group. The meta-analysis shows that vitamin D supplementation could improve muscle function in elderly people. 
DISCUSSION
The geriatric population is a heterogeneous age group. Individuals in this group differ in terms of age, place of living, social status, existence of chronic illnesses, and quality of life. Therefore, it is predicted that studies among the geriatric population will, in general, present mixed results unless the population is defined more precisely according to the factors mentioned previously. Therefore, we limited the present metaanalysis to community-dwelling apparently healthy elderly individuals. It is known that communitydwelling elderly populations are usually healthier than those who are hospitalized or institutionalized. Community-dwelling individuals were targeted to limit the heterogeneity among the geriatric population. The outcomes of this study were determined by the results of the HGS and the TUG tests, which are the only quantifiable outcomes that have been used as measurements of the decline in muscle strength and muscle function 1 . The aim of this meta-analysis was to investigate whether vitamin D supplementation (with or without calcium) in community-dwelling elderly individuals contributes to improved muscle function. Based on the findings of this meta-analysis, we conclude that vitamin D supplementation has a significant effect on muscle function, (HGS, p=0.043; TUG, p=0.049). This can be explained by the effect of vitamin D on type 2 muscle fibres 13. In addition to the effects of vitamin D on neuromuscular control and neural coordination, there is growing evidence supporting a neurotrophic effect of vitamin D
14.

Strengths and limitations
The strength of this meta-analysis was the usage of data from 14 RCTs, with approximately 2127 participants. The HGS and TUG tests are the only quantifiable outcomes that have been used as measurements of the decline in muscle strength and muscle function. The limitations of this study are the discrepancies between RCTs in terms of the doses of vitamin D, type of supplement, duration of supplementation, and participants' baseline vitamin D status, which made comparisons between studies difficult. 
CONCLUSION
